Versions of the OnlineCRF EDC Platform

As the OnlineCRF electronic data capture (EDC) system evolved and adapted to the unique needs of various clinical trials and research projects, we recognized the importance of offering distinct solutions tailored to different types of studies. Today, Pharmaxi provides three specialized versions of the OnlineCRF platform, each designed to meet the specific demands of diverse clinical environments.

CT Edition (Clinical Trial)

The CT Edition is designed for data collection in interventional clinical trials. This EDC system is configured according to the clinical trial protocol and supports key functions such as patient randomization and role-based access for site staff. It incorporates automated data pre-validation, ensuring high-quality data collection that meets regulatory and Good Clinical Practice (GCP) standards.

Key features of this clinical trial monitoring solution include:

Multi-site and multi-investigator support for complex clinical environments.

A built-in randomization module for patient assignment.

Customizable access rights for on-site and remote monitors.

Advanced adverse event (AE) reporting functionalities.

Automated email notifications for AE registration.

An analytics module for identifying project-critical risk factors and evaluating site performance.

This edition is an optimal choice for pharma and biotech companies seeking a reliable and regulatory-compliant EDC platform for interventional clinical research.

LPS Edition (Late Phase Study)

The LPS Edition is designed for late-phase and non-interventional clinical trials, including post-marketing, observational, epidemiological, pragmatic, and investigator-initiated studies. This version is ideal for managing large-scale research projects involving hundreds of investigators and thousands of patients. Our platform has been successfully implemented in multiple global studies, including large-scale observational studies for pharmaceutical companies like Sanofi, with participation from 100+ investigators and over 5,000 patients.

Key features of this solution include:

A hierarchical user management model: physicians access only their patients’ records, monitors oversee specific groups of physicians, while project managers view aggregated project-level data.

Simplified AE reporting process, designed specifically for late-phase and real-world evidence studies.

A real-time project dashboard providing up-to-date metrics and data summaries.

Scalable infrastructure capable of supporting up to 500 investigators and 50,000 patients.

A built-in payment module that tracks closed patient visits and automatically calculates investigator site fees.

The LPS Edition is well-suited for pharma and research companies that require an efficient system for large-scale, late-phase clinical trials.

R Edition (Registry)

The R Edition is specifically tailored for the unique demands of disease and product registries. Long-term registries often require specialized functionality, as patients may have dozens of visits and could be followed by multiple physicians over time. This system allows for seamless patient record transfers between physicians while maintaining the integrity and continuity of collected data.

Key features of this platform include:

Automatic identification of existing patient records within the system.

Secure transfer of patient records from one physician to another, preserving the visit history.

Manual moderation of patient record transfers to ensure data quality.

Flexibility to add additional visits during the course of the project, allowing for long-term or indefinite registry timelines.

The R Edition provides a powerful solution for pharma companies and research organizations conducting long-term, multi-site registry studies.

If you are looking for a flexible and compliant electronic data capture system for your clinical trials, registries, or post-marketing studies, contact Pharmaxi today. Call us at +48 739-108-217 or fill out our contact form. We also offer a free 30-minute consultation to address any questions related to clinical research, regulatory compliance, or data management.